Jefferies upgrades Centrica stock as management's track record improves

Published 29/08/2024, 08:50
Jefferies upgrades Centrica stock as management's track record improves

On Thursday, Centrica Plc. (LON:CNA:LN) (OTC: CPYYY) received a stock rating upgrade from Jefferies, moving from Hold to Buy. The firm has set a price target for Centrica (OTC:CPYYY) at GBP1.50, maintaining the same level as before the upgrade. The decision comes as the stock has seen a 10% year-to-date decline.

The upgrade reflects Jefferies' reassessment of the risk-reward balance for Centrica's shares. The firm acknowledges the management's consistent performance in the company's downstream retail and optimisation segments. These areas are considered key contributors to the firm's stock valuation.

Jefferies also recognizes the potential valuation upside from Centrica's future investments. This acknowledgment is based on increased visibility into the company's operations and prospects over the past six months. The firm's confidence in these segments has led to the positive outlook on the stock.

The price target of 150 pence implies a total shareholder return of 20%, according to Jefferies. This target remains unchanged despite the upgrade in the stock's rating, indicating a steady confidence in the company's value potential.

The upgrade to Buy suggests that Jefferies sees a favorable opportunity for investors with Centrica's current stock performance and the company's strategic direction. The firm's analysis points to a belief in the strength of Centrica's management and their ability to deliver value to shareholders.

In other recent news, Centrica Plc has seen several adjustments in analyst ratings and price targets. Berenberg upgraded Centrica's stock to 'Buy' from 'Hold', citing the company's strong cash reserves of nearly GBP3 billion. The firm also increased the price target from GBP1.30 to GBP1.55, anticipating that Centrica will utilize around GBP1 billion of its cash reserves to expand its share buyback program.

On the contrary, Goldman Sachs slightly reduced its price target for Centrica to GBP1.92 from GBP1.94, while maintaining a Conviction Buy rating. The new target is based on a P/E valuation of 172p per share and a projected cash build-up, discounted back three years.

Furthermore, RBC Capital Markets upgraded Centrica's stock rating to 'Outperform' from 'Sector Perform' and lifted its price target to GBP1.70 from GBP1.45. The firm cited a solid balance sheet and improvements in commodity markets as factors influencing the upgrade.

These recent developments reflect a generally positive outlook for Centrica from Berenberg, Goldman Sachs, and RBC Capital Markets, emphasizing the company's financial health and potential.

InvestingPro Insights

In light of Jefferies' recent upgrade of Centrica Plc. (OTC: CPYYY), a deeper dive into the company's financials through InvestingPro data reveals a nuanced picture. Centrica's management has been aggressively buying back shares, aligning with a proactive approach to capital management. Furthermore, the company holds more cash than debt on its balance sheet, which bodes well for financial stability and potential future investments.

From a valuation standpoint, Centrica is trading at a low earnings multiple with a P/E ratio of 6.2, suggesting that the stock may be undervalued compared to earnings potential. Additionally, the company is trading near its 52-week low, with a price 77.12% of its 52-week high, which could indicate a buying opportunity for investors seeking an entry point.

However, it's important to note that Centrica has experienced a significant revenue decline over the last twelve months, with a revenue growth rate of -31.59%. This is coupled with weak gross profit margins, as evidenced by a gross profit margin of -40.31%. These financial metrics underscore some of the challenges the company faces, despite the positive outlook from Jefferies.

For investors looking for a comprehensive analysis, there are over 10 additional InvestingPro Tips available, offering deeper insights into Centrica's financial health and market performance. Interested readers can find these tips and more real-time data on the InvestingPro platform at https://www.investing.com/pro/CPYYY.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.